Medical & Diagnostic Imaging is expected to reach ~USD 36.43 Billion by 2021, at a CAGR of 6.6% from 2016 to 2021. Increasing investments from public-private organizations; growth in the number of diagnostic imaging centers; rising prevalence of cancer; increasing geriatric population and the subsequent growth in the incidence of various diseases; technological advancements in diagnostic imaging modalities; and increasing preference for minimally invasive treatments drive the growth of this market.
But now investors could be starting to see a clear opportunity ahead as typical investment opportunities for direct exposure to this industry have rarely presented themselves. Then again, when a rare opportunity like this begins to raise eyebrows, the street could start to quickly take notice. So it should come as no surprise that when main stream investors come across:
Medical Imaging Corp. (MEDD)
, their heads could start to turn, quick. But they haven’t yet and for early onlookers, that could mean an open door of opportune timing! Medical Imaging Corp. (MEDD) specializes in the acquisition of existing medical imaging businesses. The company also operates CTA, a Teleradiology company that can assess and report on radiology images, such as X-rays, CTs, and MRIs, from remote locations.
(MEDD) currently own and operate 4 diagnostic imaging centers serving 4 communities and 1 radiology consulting company (teleradiology) serving 18 hospitals.
And unlike many “emerging growth” companies who are “trying” to start their businesses, (MEDD) is already producing revenues. We aren’t talking about thousands here…we’re talking MILIONS of dollars are being generated by (MEDD) RIGHT NOW. In fact from 2013 to 2016 (the last annual statement), annual revenues increased from $5.08 million to $7.2 million and if (MEDD) continues to post the same quarterly figures they did as of their last quarterly filing ($1.8 million ended March 2017), (MEDD) could already be on pace to continue this trend!
THE HERALD FINANCE REPORT
Start your workday the right way with the news that matters most.
(MEDD)’s business plan calls for the acquisition and operation of profitable diagnostic imaging facilities and imaging service businesses with a short term goal of annualized revenues of $18 million and EBITDA of $3 million and a long term goal of over $100 million in annualized revenues and EBITDA of $20 million!
Thanks to (MEDD) management, the goals are clear: build a successful operation and grow. Revenue growth can be directly correlated with corporate leadership and (MEDD) has an experienced team behind it to say the least:
Mitchell Geisler, (MEDD)’s chairman, President and CEO is a seasoned entrepreneur in the health, mining, hospitality and technology arenas, Mitch has served as the Chief Executive Officer, President and Chairman of the Board since January 2010. In addition, he has also served as President of all of the Company’s subsidiaries, Custom Teleradiology Services and Schuylkill Medical Imaging, since January 2010 and December 2012, respectively and PIV, PIN, PIC since November 2014.
Mr. Geisler was the Chief Operating Officer and a director of Pacific Gold Corp. from 2004-2014. Mr. Geisler has extensive knowledge and experience in operations, expansion, contract negotiations, capital raising, marketing, cost control and acquisitions. So you could say that his experience goes far beyond the medical arena and a diverse understanding of multiple deal structures could give him and his team a huge edge in the market!
Richard Jagodnik, CPA, CA, & director and CFO of (MEDD) has served as the Company’s
Chief Financial Officer since January 2010 and as a Director since July 2005. Prior to that, he served as Medical Imaging’s Chief Executive Officer, President and Chairman of the Board.
Richard is responsible for all aspects of Medical Imaging‘s SEC reporting, strategic planning, budgeting, project development, contract management and organizational planning. From 1997 through 2005, he served as Vice President of Finance for Interesting Displays and Ideas, a Montreal-based manufacturing organization. Richard began his career working at Friedman and Friedman, Chartered Accountants.
Being placed inside an MRI machine, Cat Scan, or other medical devices can be a nerve-racking experience for patients. At Medical Imaging Corp, the company strives to provide the best possible experience for all patients.
Take for example the company’s Schuylkill Medical Imaging facility. Claustrophobic patients can choose between a traditional closed system MRI and an Open MRI machine.
According to Zion Market Research, increasing geriatric population and growing occurrences of chronic diseases are some of the major factors driving the global diagnostic imaging market. Growth in the pharmaceutical industry is another major factor that is expected to help the growth of the diagnostic imaging in the coming years.
Government support and investments coupled with research and development activities especially in countries such as the U.S. and U.K. is anticipated to boost the market growth in the near future.
(MEDD)’s strategy is focused on acquisition instead of building from the ground up. Acquiring revenue producing, profitable centers that can bolster corporate growth. With choices outside of general practitioners’ suggestions, the quality of service offered by MEDD can offer multiple facets of customer base growth. According to the company, MEDD has mostly spent cash to acquire these facilities, which may lend itself to less dilutive scenarios in the market.
But it isn’t just companies like this who are acquiring imaging firms. The even bigger fish could already be targeting companies like (MEDD) to bring on immediate revenue streams. These acquisitions are not for small sums either.
Will (MEDD) Be Next?
The fact that some of the biggest names in technology are finding huge value and acquisitions in the multi-billion dollar range, for medical imaging companies could come as a well-timed opportunity for those looking for public companies still flying under the radar of main street traders (for now).
Let history be your guide. And remember, there are very few companies like this in the medical imaging and medical device space that come across the desks of investors…but when they do, the windfalls can be massive!
Shares of Radnet Inc. traded UNDER $2 per share and ended up running as high as $10.35 within a matter of months!
Quest Diagnostics shares traded at a mere $7.75, ended up running over 1,300% to highs of $112.96 and still trade today at more than $100 a share!
And early investors able to grab shares of DaVita when it was trading under $0.70 could have had a chance to turn a small $1,000 investment into $122,880!
All this from well-timed investments into medical device and medical imaging companies! Right now (MEDD) is trading at a fraction of these with recent price levels BELOW 20 cents! Forget years, seeing these kinds of medical imaging breakouts, could you imagine where (MEDD) could be in just a few months?
What will you do?
Early investors who acted on their gut could have reaped life-changing rewards from well-timed moves in medical imaging stocks. Opportunities to see a pure pay company within the space during its early stages don’t come along often but as you can see, when they do, there could be massive potential for a breakout.
The bottom line is that medical imaging stocks have been known to deliver some of the most aggressive and highest percentage gains.
With sound leadership, an active pipeline, a novel expansionary blue print, and its latest growth strategy, (MEDD) could be one of the hottest public medical imaging companies the Street has yet to see for themselves.
Early investors could be set to take advantage of one of the biggest cash grabs the industry could see in 2017!
HeraldFinance.com is owned by MAD Media Publishing LLC., a Nevada corporation. (“HF”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. (“HF”) has not been compensated: an affiliate company of (“HF”) MIDAM VENTURES LLC has been compensated $150,000 by a non-affiliate 3rd party for a period beginning 8/8/2017 and ending 9/7/2017 to publicly disseminate information about MEDD. We own zero shares. MIDAM’s FULL DISCLAIMER HERE